Lead
The daycare said the pool is off-limits until the molluscum clears up. The dermatologist suggested removing them, but the procedure looked painful. And somewhere along the way you heard that they just go away on their own.
This article lays out the two options — treat or wait — against what the evidence actually says about molluscum contagiosum (water warts).
What Molluscum Contagiosum Is
Molluscum contagiosum is a skin infection caused by the molluscum contagiosum virus (MCV), a member of the poxvirus: family of large double-stranded DNA viruses that replicate in the cell's cytoplasm and cause characteristic skin lesions family. It produces small, pearly papules: small, firm, raised bumps on the skin surface, less than 1 cm wide — typically 2–5 mm in diameter — scattered across the trunk, limbs, and face. In children with a competent immune system, it is a benign condition that resolves on its own.
Prevalence in young children is roughly 5–8%, with higher rates in children attending daycare [2]. The virus spreads through direct skin-to-skin contact and indirectly via shared towels and play equipment.
The Reality of Natural Resolution
Molluscum is widely described as self-limiting — but "self-limiting" takes time. Longitudinal studies tracking prevalence show that about 65–70% of cases resolve spontaneously within 18 months, and virtually all within 24 months [2]. In other words, natural resolution happens, but over one to two years rather than a few weeks.
During that waiting period, the number of lesions may increase — a common occurrence during the natural course. In children with atopic dermatitis, molluscum can trigger eczema flares [3]. That said, widespread or severe disease in immunocompetent children is rare.
What the Evidence Says About Treatment
The main treatments used in practice are:
- Mechanical removal (curettage): the most widely used, but involves pain and procedural distress for the child
- Silver nitrate paste or liquid nitrogen: chemical or cryotherapy approaches
- Cantharidin: a toxic compound from blister beetles that destroys the top skin layer, causing blistering and lesion removal (a blistering agent derived from blister beetles): not covered by insurance in Japan; used in some other countries
- Imiquimod cream: an immune-response modifier: topical drug that activates the body's own immune system to attack virus-infected skin cells; mainly used in treatment-resistant cases
The 2017 Cochrane systematic review evaluated these approaches comprehensively. Its conclusion: there is currently insufficient evidence that active treatment is significantly superior to watchful waiting [1]. When the harms — pain, scarring, procedural anxiety — are factored in, the trade-offs for most treatments are not clear.
There are situations where treatment becomes a reasonable conversation with a physician: rapidly increasing lesion count, worsening atopic dermatitis, or clear transmission to a sibling or contact with eczema. But these are contextual decisions rather than defaults.
Daycare and School Policies
In Japan, a persistent practice in some facilities has been to prohibit children with molluscum from using the pool. However, the Japanese Society of Pediatric Dermatology has stated clearly that molluscum does not warrant swimming exclusion [5].
Molluscum contagiosum is also not listed under the School Health Safety Act as a disease requiring exclusion from attendance. The primary route of transmission is skin contact and shared towels — not pool water itself — so there is little medical basis for banning pool use.
When a daycare or school imposes swimming or attendance restrictions, parents have a practical option: bring the society's position to a conversation with the facility. Asking a physician to write a brief explanatory note for the school is also done in practice.
When Choosing Not to Treat Is the Right Call
Given the Cochrane review's conclusions, choosing not to treat is a medically grounded option. The following situations are ones where waiting may spare the child unnecessary discomfort:
- The child is young and difficult to keep still during procedures
- The child has strong fear of pain, and a difficult clinical experience could affect future willingness to seek care
- The number of lesions is small and there is no sign of increase
Choosing to treat is also not irrational. Facility rules, a sharp rise in lesion count, or a parent's own anxiety about waiting are all legitimate motivations. Treatment options exist and can be discussed with a physician.
What matters is not which choice is "correct" but rather making a decision that fits the child's specific situation — informed by where the evidence actually stands.
Summary
Molluscum contagiosum is a benign, self-limiting condition, and strong evidence that active treatment outperforms watchful waiting does not currently exist. The treatment decision depends on the child's age, pain tolerance, facility policies, and family preferences. The evidence base for pool exclusion is thin. Having a grasp of these facts changes the quality of the conversation you can have at the clinic.
References
- van der Wouden JC, van der Sande R, Kruithof EJ, Sollie A, van Suijlekom-Smit LW, Koning S. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2017;5(5):CD004767. doi:10.1002/14651858.CD004767.pub4. PMID: 28513067.
- Olsen JR, Gallacher J, Piguet V, Francis NA. Epidemiology of molluscum contagiosum in children: a systematic review. Fam Pract. 2014;31(2):130–136. doi:10.1093/fampra/cmt075. PMID: 24297656.
- Silverberg NB. Molluscum contagiosum virus infection can trigger atopic dermatitis disease onset or flare. Cutis. 2000;65(4):247–251. PMID: 10780964.
- Hanna D, Hatami A, Powell J, et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatr Dermatol. 2006;23(6):574–579. doi:10.1111/j.1525-1470.2006.00312.x. PMID: 17155994.
- Japanese Society of Pediatric Dermatology. Position on the management of molluscum contagiosum (Densenshiyananzoku, water warts). 2010.